Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Reid

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Obesity (2005)|March 3, 2010
Economic implications of obesity among people with atherothrombotic diseaseZ Ademi, H L Walls, A Peeters, et al.
Internal Medicine Journal|September 6, 2013
Author reply: To PMID 22909211D J Campbell, M McGrady, D L Prior, et al.
American Journal of Hypertension|June 20, 2001
Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the ElderlyC D Gatzka, J D Cameron, A M Dart, et al.
BJS Open|September 28, 2020
Australasian ACPGBI risk prediction model for 30-day mortality after colorectal cancer surgeryS Wilkins, K Oliva, E Chowdhury, et al.
Internal Medicine Journal|August 23, 2012
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classesD J Campbell, M McGrady, D L Prior, et al.
Journal of Hypertension|November 29, 2001
Gender differences in the timing of arterial wave reflection beyond differences in body heightC D Gatzka, B A Kingwell, J D Cameron, et al.
International Journal of Cardiology|January 3, 2022
Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failureA Driscoll, H Romaniuk, D Dinh, et al.
Internal Medicine Journal|February 25, 2016
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary interventionM B Yudi, D J Clark, O Farouque, et al.
European Heart Journal|May 23, 2017
Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trialP A Scuffham, J Ball, J D Horowitz, et al.
Internal Medicine Journal|March 11, 2014
Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspectiveA L Brennan, N Andrianopoulos, S J Duffy, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Obesity (2005)|March 3, 2010
Economic implications of obesity among people with atherothrombotic diseaseZ Ademi, H L Walls, A Peeters, et al.
Internal Medicine Journal|September 6, 2013
Author reply: To PMID 22909211D J Campbell, M McGrady, D L Prior, et al.
American Journal of Hypertension|June 20, 2001
Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the ElderlyC D Gatzka, J D Cameron, A M Dart, et al.
BJS Open|September 28, 2020
Australasian ACPGBI risk prediction model for 30-day mortality after colorectal cancer surgeryS Wilkins, K Oliva, E Chowdhury, et al.
Internal Medicine Journal|August 23, 2012
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classesD J Campbell, M McGrady, D L Prior, et al.
Journal of Hypertension|November 29, 2001
Gender differences in the timing of arterial wave reflection beyond differences in body heightC D Gatzka, B A Kingwell, J D Cameron, et al.
International Journal of Cardiology|January 3, 2022
Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failureA Driscoll, H Romaniuk, D Dinh, et al.
Internal Medicine Journal|February 25, 2016
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary interventionM B Yudi, D J Clark, O Farouque, et al.
European Heart Journal|May 23, 2017
Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trialP A Scuffham, J Ball, J D Horowitz, et al.
Internal Medicine Journal|March 11, 2014
Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspectiveA L Brennan, N Andrianopoulos, S J Duffy, et al.
Pageof 6